Cargando…
MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
BACKGROUND: The active metabolite of 5-Fluorouracil (5FU), used in the treatment of several types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene, which catalyzes the rate-limiting step in DNA replication. The major failure of 5FU-based cancer therapy is the developme...
Autor principal: | Matuszyk, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351108/ https://www.ncbi.nlm.nih.gov/pubmed/35922756 http://dx.doi.org/10.1186/s10020-022-00516-2 |
Ejemplares similares
-
Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
por: Wong, N A C S, et al.
Publicado: (2001) -
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
por: Nagaraju, Ganji Purnachandra, et al.
Publicado: (2014) -
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
por: Haritha, Nair Hariprasad, et al.
Publicado: (2021) -
Effect of Hammerhead Ribozyme against Human Thymidylate Synthase on the Cytotoxicity of Thymidylate Synthase Inhibitors
por: Kobayashi, Hiroyuki, et al.
Publicado: (1995) -
MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression
por: Chen, Wei, et al.
Publicado: (2017)